We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$5.85B
AUM Growth
-$145M
Cap. Flow
-$400M
Cap. Flow %
-6.83%
Top 10 Hldgs %
13.17%
Holding
280
New
19
Increased
117
Reduced
131
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 16.99%
2 Industrials 15.29%
3 Financials 13.49%
4 Healthcare 12.83%
5 Consumer Discretionary 12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABMD
276
DELISTED
Abiomed Inc
ABMD
-24,122
Closed -$4.07M
CAA
277
DELISTED
CalAtlantic Group, Inc.
CAA
-1,060,982
Closed -$38.9M
BETR
278
DELISTED
Amplify Snack Brands, Inc.
BETR
-1,133,751
Closed -$8.04M
NAVG
279
DELISTED
Navigators Group Inc
NAVG
-3,611
Closed -$211K
NDRM
280
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
-97,120
Closed -$3.78M

Similar funds

GW&K Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, GW&K Investment Management held 280 positions worth $5.85B, down 2.4% from $6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

GW&K Investment Management withdrew a net $400M in Q4 2017, closing 11 positions and reducing 131 holdings. Its most notable exit was Syneos Health, Inc. Class A Common Stock, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, GW&K Investment Management opened a new position in Amgen worth $35.2M.

  • GW&K Investment Management's largest Q4 2017 buy was Amgen: 202,307 shares worth $35.2M.
  • GW&K Investment Management added most to Impax Laboratories, Inc. in Q4 2017, an estimated $20.3M increase.
  • GW&K Investment Management's biggest Q4 2017 reduction was Sun Communities, cutting an estimated $33.2M.
  • GW&K Investment Management fully exited Syneos Health, Inc. Class A Common Stock in Q4 2017, selling an estimated $43.9M.
  • GW&K Investment Management's ten largest holdings make up 13% of its $5.85B portfolio in Q4 2017.
  • GW&K Investment Management opened 19 new positions and closed 11 in Q4 2017.
  • GW&K Investment Management's portfolio value fell 2.4% quarter-over-quarter to $5.85B.

Based on GW&K Investment Management's 13F filing for Q4 2017, filed 19 Jan 2018.